Dallas Jury Awards $247 Million to Six New York Patients Over J&J's Defective Pinnacle Hip Implants
After trial: The Pinnacle hip claims were later resolved in a global settlement of about $1 billion in 2019.
Won by The Lanier Law Firm.
A Dallas federal jury awarded six New York patients $247 million against Johnson and Johnson and its DePuy unit, finding that the metal-on-metal Pinnacle hip implant system was defectively designed and that the company concealed known risks from patients and surgeons.
What happened
DePuy Orthopaedics marketed its Pinnacle Acetabular Cup System as a long-lasting solution for patients who needed total hip replacement. The device was built around a metal-on-metal bearing: a cobalt-chromium ball rotating inside a cobalt-chromium socket. That friction, sustained over years of daily movement, shed metallic particles and ions into surrounding tissue. For a significant portion of recipients, the debris triggered metallosis, a condition involving tissue death, bone erosion, and severe inflammation that typically required revision surgery to remove and replace the device. DePuy discontinued the Pinnacle metal-on-metal line in 2013, following regulatory changes and mounting failure data.
By late 2017, more than 9,000 cases involving the Pinnacle implant had been consolidated before U.S. District Judge Ed Kinkeade in the Northern District of Texas as part of MDL 2244. Six residents of New York, ranging in age from 52 to 88 and spanning a variety of occupations and backgrounds, had each undergone implant surgery and later faced painful revisions. Their cases were selected as the fourth set of bellwether trials in the litigation, designed to test how juries would evaluate the evidence and the plaintiffs' injuries.
W. Mark Lanier led trial counsel for the six plaintiffs through a nine-week proceeding. The plaintiffs' theory centered on two points: that the metal-on-metal design was unreasonably dangerous given the known wear characteristics of cobalt-chromium components, and that DePuy's own executives were aware of the elevated failure and ion-release risks yet directed sales representatives to tell surgeons the device had been improved rather than disclose the underlying data. Internal company communications became key evidence at trial.
The jury deliberated for 14 hours before returning, on November 16, 2017, a total verdict of $247 million. The award comprised $78 million in compensatory damages across the six plaintiffs and $168 million in punitive damages against J&J and DePuy. It was Lanier's third consecutive plaintiff victory in the Pinnacle bellwether series.
Johnson and Johnson disputed the verdict and was expected to appeal. The earlier Pinnacle bellwether verdicts in this MDL ($502 million from trial one and $1.04 billion from trial two) were both subsequently reduced or challenged in post-trial and appellate proceedings, a pattern the company indicated it intended to pursue with all bellwether outcomes.
Sources
This account is drawn from contemporaneous public reporting and the court record.
More proven verdicts from The Lanier Law Firm
All The Lanier Law Firm proven verdicts →As chair of the plaintiffs' negotiating committee and Liaison Counsel in the Vioxx multidistrict litigation, Russ Herman directed the negotiations that produced a $4.85 billion settlement with Merck resolving approximately 45,000 to 50,000 personal-injury claims.
A St. Louis jury in July 2018 awarded 22 women and their families $4.69 billion, the largest U.S. verdict of that year, finding that asbestos in Johnson & Johnson's talcum powder products caused ovarian cancer; a Missouri appellate court upheld $2.11 billion in 2020.
After a six-week federal trial, a jury found three of the nation's largest retail pharmacy chains created a public nuisance by flooding Lake and Trumbull Counties, Ohio with opioid pills, and a judge ordered $650 million to fund a 15-year abatement plan.
A Dallas federal jury awarded $1.04 billion to six California patients harmed by Johnson and Johnson's metal-on-metal Pinnacle hip implants, with W. Mark Lanier leading an eight-week trial that produced one of the largest product-liability verdicts of 2016.
Related product liability verdicts
Sullivan Papain was among the firms representing New York State against Philip Morris, R.J. Reynolds, Brown & Williamson, and Lorillard, securing a $25 billion recovery through the 1998 Master Settlement Agreement.
C. Steven Yerrid, the youngest of Florida's 11-lawyer 'Dream Team,' added racketeering and conspiracy charges that tripled the damages ceiling, helping the state secure what was then the largest civil settlement in American history against the tobacco industry.
As co-lead counsel in the federal Roundup multidistrict litigation and the first firm to sue Monsanto in 2015, Weitz and Luxenberg helped negotiate a $10.9 billion settlement resolving approximately 125,000 non-Hodgkin lymphoma claims against Bayer-owned Monsanto.
After fifteen years of litigation and three failed bankruptcy maneuvers by Johnson and Johnson subsidiaries, Ashcraft and Gerel attorneys R. Bryant McCulley and Michelle Parfitt helped negotiate a global, uncapped settlement of at least $5.5 billion covering approximately 76,000 ovarian-cancer claims.